InVitro International
IVRO · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $1 | $1 |
| - Cash | $1 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $1 | $0 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 8.3% | 2.4% | -7.1% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 81.7% | 80.6% | 80.2% | 79.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 14.7% | 13.8% | 0.8% | 1.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 13.9% | 13.2% | 0.2% | 2.5% |
| EPS Diluted | 0.005 | 0.005 | 0 | 0.001 |
| % Growth | 17.8% | 4,400% | -88.9% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |